![Sunil Rao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Sunil Rao.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Armed Forces Medical College
1
| College/University | Other Consumer Services | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Sunil Rao a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
GILEAD SCIENCES, INC. | Biotechnology | President | |
Samsara Biocapital LLC
![]() Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Celera Corp.
![]() Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
University of Michigan | College/University | Graduate Degree | |
OrsoBio Inc
![]() OrsoBio Inc Miscellaneous Commercial ServicesCommercial Services Orsobio, Inc. is a clinical-stage biopharmaceutical company that focuses on developing therapies to treat obesity and other severe metabolic disorders, such as type 2 diabetes, NASH, and severe dyslipidemias. The company is based in Palo Alto, CA. The company has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism. Orsobio has a team of physicians and scientists who are dedicated to developing therapies to treat organ failure in patients with severe metabolic disorders. The company was founded by Mani Subramanian, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 7 |
Sectorial
Health Technology | 3 |
Finance | 2 |
Health Services | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Operativa
Director/Board Member | 2 |
President | 1 |
Private Equity Investor | 1 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Las relaciones más conectadas
Insiders | |
---|---|
Mani Subramanian | 7 |
- Bolsa de valores
- Insiders
- Sunil Rao
- Conexiones Empresas